계산
총 자산 회전율 | = | 영업1 | ÷ | 총 자산1 | |
---|---|---|---|---|---|
2024. 12. 31. | 0.31 | = | 23,875) | ÷ | 77,542) |
2023. 12. 31. | 0.28 | = | 23,890) | ÷ | 84,488) |
2022. 12. 31. | 0.37 | = | 31,471) | ÷ | 84,350) |
2021. 12. 31. | 0.35 | = | 29,453) | ÷ | 83,184) |
2020. 12. 31. | 0.29 | = | 22,284) | ÷ | 76,161) |
2019. 12. 31. | 0.29 | = | 17,911) | ÷ | 62,082) |
2018. 12. 31. | 0.42 | = | 19,893) | ÷ | 47,833) |
2017. 12. 31. | 0.39 | = | 18,330) | ÷ | 46,649) |
2016. 12. 31. | 0.37 | = | 16,882) | ÷ | 45,295) |
2015. 12. 31. | 0.43 | = | 20,563) | ÷ | 48,222) |
2014. 12. 31. | 0.54 | = | 19,914) | ÷ | 36,992) |
2013. 12. 31. | 0.55 | = | 19,118) | ÷ | 34,672) |
2012. 12. 31. | 0.55 | = | 18,260) | ÷ | 32,941) |
2011. 12. 31. | 0.54 | = | 16,091) | ÷ | 29,949) |
2010. 12. 31. | 0.59 | = | 13,203) | ÷ | 22,217) |
2009. 12. 31. | 0.57 | = | 11,185) | ÷ | 19,595) |
2008. 12. 31. | 0.73 | = | 12,697) | ÷ | 17,490) |
2007. 12. 31. | 0.63 | = | 11,026) | ÷ | 17,472) |
2006. 12. 31. | 0.75 | = | 9,596) | ÷ | 12,864) |
2005. 12. 31. | 0.87 | = | 7,985) | ÷ | 9,163) |
보고서 기준: 10-K (보고 날짜: 2024-12-31), 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
1 US$ 단위: 백만 달러
경쟁사와의 비교
Danaher Corp. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024. 12. 31. | 0.31 | 0.42 | 0.35 | 0.52 | 0.57 | 0.48 | 0.49 | 0.55 | 0.30 | 0.38 | 0.44 | 0.49 |
2023. 12. 31. | 0.28 | 0.40 | 0.28 | 0.47 | 0.53 | 0.43 | 0.51 | 0.56 | 0.26 | 0.40 | 0.43 | 0.43 |
2022. 12. 31. | 0.37 | 0.42 | 0.38 | 0.48 | 0.58 | 0.43 | 0.51 | 0.54 | 0.51 | 0.42 | 0.46 | 0.49 |
2021. 12. 31. | 0.35 | 0.38 | 0.40 | 0.42 | 0.58 | 0.40 | 0.52 | 0.46 | 0.45 | 0.63 | 0.41 | 0.56 |
2020. 12. 31. | 0.29 | 0.30 | 0.39 | 0.36 | 0.53 | 0.36 | 0.47 | 0.52 | 0.28 | 0.50 | 0.47 | 0.53 |
2019. 12. 31. | 0.29 | 0.37 | 0.37 | 0.20 | 0.57 | 0.36 | 0.52 | 0.55 | 0.31 | 0.53 | 0.44 | 0.50 |
2018. 12. 31. | 0.42 | 0.55 | 0.34 | 0.64 | 0.56 | 0.34 | 0.53 | 0.51 | 0.34 | 0.57 | 0.43 | 0.49 |
2017. 12. 31. | 0.39 | 0.40 | 0.27 | 0.62 | 0.51 | 0.37 | 0.49 | 0.46 | 0.31 | 0.67 | 0.37 | 0.70 |
2016. 12. 31. | 0.37 | 0.39 | 0.28 | 0.58 | 0.55 | 0.53 | 0.51 | 0.42 | 0.31 | 0.70 | 0.40 | 0.59 |
2015. 12. 31. | 0.43 | 0.43 | 0.29 | 0.52 | 0.56 | 0.62 | 0.53 | 0.39 | 0.29 | 0.73 | 0.41 | 0.41 |
2014. 12. 31. | 0.54 | 0.72 | 0.28 | 0.47 | 0.53 | 0.71 | 0.57 | 0.43 | 0.29 | 0.73 | 0.39 | 0.25 |
2013. 12. 31. | 0.55 | 0.64 | 0.28 | 0.42 | 0.66 | 0.48 | 0.54 | 0.42 | 0.30 | 0.71 | 0.41 | 0.52 |
2012. 12. 31. | 0.55 | 0.68 | 0.31 | 0.49 | 0.66 | 0.44 | 0.55 | 0.45 | 0.32 | 0.66 | 0.46 | 0.55 |
2011. 12. 31. | 0.54 | — | 0.31 | 0.64 | 0.72 | 0.47 | 0.57 | 0.46 | 0.36 | 0.34 | 0.44 | 0.64 |
2010. 12. 31. | 0.59 | — | 0.34 | 0.63 | 0.74 | 0.64 | 0.60 | 0.43 | 0.35 | 0.42 | 0.51 | 0.08 |
2009. 12. 31. | 0.57 | — | 0.36 | 0.61 | 0.80 | 0.67 | 0.65 | 0.24 | 0.23 | 0.51 | 0.47 | 0.05 |
2008. 12. 31. | 0.73 | — | 0.40 | 0.70 | 0.70 | 0.72 | 0.75 | 0.51 | 0.43 | 0.36 | 0.50 | 0.18 |
2007. 12. 31. | 0.63 | — | 0.41 | 0.74 | 0.70 | 0.64 | 0.75 | 0.50 | 0.42 | 0.13 | 0.46 | 0.33 |
2006. 12. 31. | 0.75 | — | 0.41 | 0.70 | 0.71 | 0.63 | 0.76 | 0.51 | 0.42 | 0.11 | 0.18 | 0.23 |
2005. 12. 31. | 0.87 | — | 0.41 | 0.68 | 0.60 | 0.48 | 0.87 | 0.49 | 0.44 | 0.16 | 0.62 | 0.29 |
보고서 기준: 10-K (보고 날짜: 2024-12-31), 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
산업 부문과의 비교: 제약, 생명공학 및 생명과학
Danaher Corp. | 제약, 생명공학 및 생명과학 | |
---|---|---|
2024. 12. 31. | 0.31 | 0.43 |
2023. 12. 31. | 0.28 | 0.40 |
2022. 12. 31. | 0.37 | 0.47 |
2021. 12. 31. | 0.35 | 0.45 |
2020. 12. 31. | 0.29 | 0.39 |
2019. 12. 31. | 0.29 | 0.39 |
2018. 12. 31. | 0.42 | 0.45 |
2017. 12. 31. | 0.39 | 0.40 |
2016. 12. 31. | 0.37 | 0.41 |
2015. 12. 31. | 0.43 | 0.42 |
2014. 12. 31. | 0.54 | 0.44 |
2013. 12. 31. | 0.55 | 0.43 |
2012. 12. 31. | 0.55 | 0.45 |
2011. 12. 31. | 0.54 | 0.47 |
2010. 12. 31. | 0.59 | 0.47 |
2009. 12. 31. | 0.57 | 0.39 |
2008. 12. 31. | 0.73 | 0.57 |
2007. 12. 31. | 0.63 | 0.56 |
2006. 12. 31. | 0.75 | 0.54 |
2005. 12. 31. | 0.87 | 0.57 |
보고서 기준: 10-K (보고 날짜: 2024-12-31), 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
업계와의 비교: 의료
Danaher Corp. | 의료 | |
---|---|---|
2024. 12. 31. | 0.31 | 0.65 |
2023. 12. 31. | 0.28 | 0.63 |
2022. 12. 31. | 0.37 | 0.66 |
2021. 12. 31. | 0.35 | 0.62 |
2020. 12. 31. | 0.29 | 0.57 |
2019. 12. 31. | 0.29 | 0.57 |
2018. 12. 31. | 0.42 | 0.63 |
2017. 12. 31. | 0.39 | 0.56 |
2016. 12. 31. | 0.37 | 0.57 |
2015. 12. 31. | 0.43 | 0.55 |
2014. 12. 31. | 0.54 | 0.60 |
2013. 12. 31. | 0.55 | 0.58 |
2012. 12. 31. | 0.55 | 0.58 |
2011. 12. 31. | 0.54 | 0.61 |
2010. 12. 31. | 0.59 | 0.61 |
2009. 12. 31. | 0.57 | 0.55 |
2008. 12. 31. | 0.73 | 0.73 |
2007. 12. 31. | 0.63 | 0.71 |
2006. 12. 31. | 0.75 | 0.69 |
2005. 12. 31. | 0.87 | 0.66 |
보고서 기준: 10-K (보고 날짜: 2024-12-31), 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).